| [1] |
杨晨光, 徐志巧. 驱动基因阳性晚期非小细胞肺癌靶向治疗[J]. 国际肿瘤学杂志, 2021, 48(4): 235-240. DOI: 10.3760/cma.j.cn371439-20200911-00047.
doi: 10.3760/cma.j.cn371439-20200911-00047
|
| [2] |
Subbiah V, Yang D, Velcheti V, et al. State-of-the-art strategies for targeting RET-dependent cancers[J]. J Clin Oncol, 2020, 38(11): 1209-1221. DOI: 10.1200/JCO.19.02551.
doi: 10.1200/JCO.19.02551
pmid: 32083997
|
| [3] |
Li AY, McCusker MG, Russo A, et al. RET fusions in solid tumors[J]. Cancer Treat Rev, 2019, 81: 101911. DOI: 10.1016/j.ctrv.2019.101911.
doi: 10.1016/j.ctrv.2019.101911
|
| [4] |
Tan AC, Seet AOL, Lai GGY, et al. Molecular characterization and clinical outcomes in RET-rearranged NSCLC[J]. J Thorac Oncol, 2020, 15(12): 1928-1934. DOI: 10.1016/j.jtho.2020.08.011.
doi: 10.1016/j.jtho.2020.08.011
|
| [5] |
郑玉军, 姜巍, 陈东妍, 等. RET融合型非小细胞肺癌的研究进展[J]. 中国肺癌杂志, 2021, 24(8): 591-597. DOI: 10.3779/j.issn.1009-3419.2021.102.22.
doi: 10.3779/j.issn.1009-3419.2021.102.22
|
| [6] |
Gainor JF, Curigliano G, Kim DW, et al. Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1/2 study[J]. Lancet Oncol, 2021, 22(7): 959-969. DOI: 10.1016/S1470-2045(21)00247-3.
doi: 10.1016/S1470-2045(21)00247-3
|
| [7] |
Piotrowska Z, Isozaki H, Lennerz JK, et al. Landscape of acquired resistance to osimertinib in EGFR-mutant NSCLC and clinical validation of combined EGFR and RET inhibition with osimertinib and BLU-667 for acquired RET fusion[J]. Cancer Discov, 2018, 8(12): 1529-1539. DOI: 10.1158/2159-8290.CD-18-1022.
doi: 10.1158/2159-8290.CD-18-1022
pmid: 30257958
|
| [8] |
Parker NA, McBride C, Forge J, et al. Bowel obstruction caused by colonic metastasis of lung adenocarcinoma: a case report and literature review[J]. World J Surg Oncol, 2019, 17(1): 63. DOI: 10.1186/s12957-019-1611-y.
doi: 10.1186/s12957-019-1611-y
pmid: 30961608
|
| [9] |
Antler AS, Ough Y, Pitchumoni CS, et al. Gastrointestinal metastases from malignant tumors of the lung[J]. Cancer, 1982, 49(1): 170-172.DOI： 10.1002/1097-0142（19820101）49：1<170：：aid-cncr2820490134>3.0.co；2-a.
pmid: 6274500
|
| [10] |
Stenbygaard LE, Sørensen JB. Small bowel metastases in non-small cell lung cancer[J]. Lung Cancer, 1999, 26(2): 95-101. DOI: 10.1016/s0169-5002(99)00075-6.
doi: 10.1016/s0169-5002(99)00075-6
pmid: 10568680
|
| [11] |
McNeill PM, Wagman LD, Neifeld JP. Small bowel metastases from primary carcinoma of the lung[J]. Cancer, 1987, 59(8): 1486-1489.DOI： 10.1002/1097-0142（19870415）59：8<1486：：aid-cncr2820590815>3.0.co；2-w.
pmid: 3028602
|
| [12] |
Rossi G, Marchioni A, Romagnani E, et al. Primary lung cancer presenting with gastrointestinal tract involvement: clinicopathologic and immunohistochemical features in a series of 18 consecutive cases[J]. J Thorac Oncol, 2007, 2(2): 115-120. DOI: 10.1016/S1556-0864(15)30037-X.
doi: 10.1016/S1556-0864(15)30037-X
|
| [13] |
Gitt SM, Flint P, Fredell CH, et al. Bowel perforation due to metastatic lung cancer[J]. J Surg Oncol, 1992, 51(4): 287-291. DOI: 10.1002/jso.2930510417.
doi: 10.1002/jso.2930510417
pmid: 1434663
|
| [14] |
Salemis NS, Nikou E, Liatsos C, et al. Small bowel perforation secondary to metastatic non-small cell lung cancer. A rare entity with a dismal prognosis[J]. J Gastrointest Cancer, 2012, 43(3): 391-395. DOI: 10.1007/s12029-011-9329-2.
doi: 10.1007/s12029-011-9329-2
|
| [15] |
Taira N, Kawabata T, Gabe A, et al. Analysis of gastrointestinal metastasis of primary lung cancer: clinical characteristics and prognosis[J]. Oncol Lett, 2017, 14(2): 2399-2404. DOI: 10.3892/ol.2017.6382.
doi: 10.3892/ol.2017.6382
|
| [16] |
Hu Y, Feit N, Huang Y, et al. Gastrointestinal metastasis of primary lung cancer: an analysis of 366 cases[J]. Oncol Lett, 2018, 15(6): 9766-9776. DOI: 10.3892/ol.2018.8575.
doi: 10.3892/ol.2018.8575
|
| [17] |
Di JZ, Peng JY, Wang ZG. Prevalence, clinicopathological cha-racteristics, treatment, and prognosis of intestinal metastasis of primary lung cancer: a comprehensive review[J]. Surg Oncol, 2014, 23(2): 72-80. DOI: 10.1016/j.suronc.2014.02.004.
doi: 10.1016/j.suronc.2014.02.004
|
| [18] |
Moreno-Aguilera E, Galeana-Nogueda FI, Vera-Aguilera J, et al. Jejunal perforation secondary to pulmonary mucoepidermoid carcinoma metastasis. Case report and review[J]. Cir Cir, 2017, 85(3): 254-259. DOI: 10.1016/j.circir.2016.03.006.
doi: S0009-7411(16)30018-4
pmid: 27260218
|
